352 related articles for article (PubMed ID: 33861449)
1. Beneficial Effects of Plant-Derived Natural Products on Non-alcoholic Fatty Liver Disease.
Simental-Mendía LE; Gamboa-Gómez CI; Guerrero-Romero F; Simental-Mendía M; Sánchez-García A; Rodríguez-Ramírez M
Adv Exp Med Biol; 2021; 1308():257-272. PubMed ID: 33861449
[TBL] [Abstract][Full Text] [Related]
2. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
Faghihzadeh F; Adibi P; Hekmatdoost A
Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
[TBL] [Abstract][Full Text] [Related]
3. Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products.
Xu G; Huang K; Zhou J
Curr Med Chem; 2018; 25(8):889-907. PubMed ID: 28393690
[TBL] [Abstract][Full Text] [Related]
4. Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress.
Gong P; Long H; Guo Y; Wang Z; Yao W; Wang J; Yang W; Li N; Xie J; Chen F
J Ethnopharmacol; 2024 Jan; 318(Pt B):116927. PubMed ID: 37532073
[TBL] [Abstract][Full Text] [Related]
5. It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them?
Tarantino G; Balsano C; Santini SJ; Brienza G; Clemente I; Cosimini B; Sinatti G
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948230
[TBL] [Abstract][Full Text] [Related]
6. Hepatoprotective Effects of Resveratrol in Non-Alcoholic Fatty Live Disease.
Tejada S; Capó X; Mascaró CM; Monserrat-Mesquida M; Quetglas-Llabrés MM; Pons A; Tur JA; Sureda A
Curr Pharm Des; 2021; 27(22):2558-2570. PubMed ID: 32303170
[TBL] [Abstract][Full Text] [Related]
7. Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease.
Abenavoli L; Larussa T; Corea A; Procopio AC; Boccuto L; Dallio M; Federico A; Luzza F
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33546130
[TBL] [Abstract][Full Text] [Related]
8. Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.
Salomone F; Godos J; Zelber-Sagi S
Liver Int; 2016 Jan; 36(1):5-20. PubMed ID: 26436447
[TBL] [Abstract][Full Text] [Related]
9. Effects of resveratrol and other polyphenols in hepatic steatosis.
Aguirre L; Portillo MP; Hijona E; Bujanda L
World J Gastroenterol; 2014 Jun; 20(23):7366-80. PubMed ID: 24966607
[TBL] [Abstract][Full Text] [Related]
10. Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds.
Ragab SM; Abd Elghaffar SKh; El-Metwally TH; Badr G; Mahmoud MH; Omar HM
Lipids Health Dis; 2015 Jul; 14():83. PubMed ID: 26228038
[TBL] [Abstract][Full Text] [Related]
11. Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin.
Feng WW; Kuang SY; Tu C; Ma ZJ; Pang JY; Wang YH; Zang QC; Liu TS; Zhao YL; Xiao XH; Wang JB
Biomed Pharmacother; 2018 Mar; 99():325-333. PubMed ID: 29353208
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
Faghihzadeh F; Adibi P; Rafiei R; Hekmatdoost A
Nutr Res; 2014 Oct; 34(10):837-43. PubMed ID: 25311610
[TBL] [Abstract][Full Text] [Related]
13. Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.
Cicero AFG; Colletti A; Bellentani S
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30142943
[TBL] [Abstract][Full Text] [Related]
14. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Sugimoto K; Inui H; Fukusato T
World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
[TBL] [Abstract][Full Text] [Related]
15. Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver Disease.
Liu Q; Zhu L; Cheng C; Hu YY; Feng Q
Curr Pharm Des; 2017; 23(34):5136-5162. PubMed ID: 28925892
[TBL] [Abstract][Full Text] [Related]
16. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Effects of Resveratrol on Nonalcoholic Fatty Liver Disease Through Inflammatory, Oxidative Stress, Metabolic, and Epigenetic Modifications.
Karimi M; Abiri B; Guest PC; Vafa M
Methods Mol Biol; 2022; 2343():19-35. PubMed ID: 34473313
[TBL] [Abstract][Full Text] [Related]
18. Effect of resveratrol on experimental non-alcoholic steatohepatitis.
Heebøll S; Thomsen KL; Clouston A; Sundelin EI; Radko Y; Christensen LP; Ramezani-Moghadam M; Kreutzfeldt M; Pedersen SB; Jessen N; Hebbard L; George J; Grønbæk H
Pharmacol Res; 2015; 95-96():34-41. PubMed ID: 25814186
[TBL] [Abstract][Full Text] [Related]
19. Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment.
Guo X; Yin X; Liu Z; Wang J
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555127
[TBL] [Abstract][Full Text] [Related]
20. Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease-A Meta-Analysis.
Jakubczyk K; Skonieczna-Żydecka K; Kałduńska J; Stachowska E; Gutowska I; Janda K
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
